Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.
Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check12 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check48 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference1%
- Check63 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information in various formats have been removed.SummaryDifference2%
- Check77 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference2%
Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.